MXCT vs SAVA
Comparison between MaxCyte Inc (MXCT, Company) and Cassava Sciences Inc. (SAVA, Company).
Both MXCT and SAVA are from the Healthcare sector.
MXCT vs SAVA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
MXCT
$115M
Winner
SAVA
$115M
Max Drawdown
MXCT
96.07%
SAVA
N/A
Sharpe Ratio
MXCT
-0.40
Winner
SAVA
0.00
5Y Beta
MXCT
1.33
Winner
SAVA
0.00
Industry
MXCT
Medical Devices
SAVA
Biotechnology
P/E Ratio
Winner
MXCT
-2.92
SAVA
-1.48
Forward P/E
MXCT
N/A
SAVA
151.52
PEG Ratio
MXCT
N/A
SAVA
-0.22
5Y EPS CAGR
MXCT
12.02%
Winner
SAVA
43.62%
Debt to Equity
MXCT
0.00%
SAVA
0.00%
Free Cash Flow Yield
Winner
MXCT
-25.61%
SAVA
-26.42%
P/S Ratio
MXCT
3.55
Winner
SAVA
2.54
P/B Ratio
Winner
MXCT
0.67
SAVA
0.92
MXCT vs SAVA - Historical Returns
Returns include dividend reinvestment.
1M
MXCT
-8.53%
Winner
SAVA
+0.00%
3M
MXCT
+35.40%
SAVA
N/A
6M
MXCT
+46.04%
SAVA
N/A
1Y
MXCT
-17.48%
SAVA
N/A
5Y(CAGR)
MXCT
-40.52%
SAVA
N/A
Max(CAGR)
MXCT
-4.40%
Winner
SAVA
+0.00%
MXCT vs SAVA - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | MXCT | SAVA |
|---|---|---|
| 2026 | -23.87% | +0.00% |
| 2025 | -62.65% | N/A |
| 2024 | -16.80% | N/A |
| 2023 | -8.20% | N/A |
| 2022 | -49.63% | N/A |
| 2021 | +525.15% | N/A |
| 2020 | +0.00% | N/A |
| 2019 | +2.31% | N/A |
MXCT vs SAVA Drawdown Comparison
The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current MXCT drawdown is -93.14%.
| Rank | MXCT | SAVA |
|---|---|---|
| #1 | -96.07% Sep 3, 2021 - Mar 30, 2026 | N/A |
| #2 | -37.58% Jan 22, 2021 - Jul 30, 2021 | N/A |
| #3 | -19.65% Jul 30, 2021 - Sep 3, 2021 | N/A |
Correlation
Correlation between MXCT and SAVA is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: MXCT vs SPYSAVA vs SPY
More Comparisons
Compare with similar stocks